Patient Morbidity After Palatal Free Gingival Grafts With or Without PRF Membranes Coverage

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 27, 2017

Primary Completion Date

July 23, 2018

Study Completion Date

September 9, 2018

Conditions
Postoperative PainPostoperative ComplicationsGingival Recession
Interventions
BIOLOGICAL

Platelet rich fibrin ( PRF)

"Venous blood was collected with a butterfly needle in two 10 mL tubes without anticoagulants or other chemicals. The tubes were immediately centrifuged at 3000 rpm for 10 minutes.~At the end of centrifugation a fibrin clot (PRF) was obtained in the middle of the tube, just between the red corpuscles at the bottom and acellular plasma at the top. The PRF clot was taken from the tube and the red cells portion at the base of the clot was eliminated with sterile scissors Then the PRF was enveloped in sterile gauzes and positioned between two glass plates: the compression drove out the serum from the clot obtaining PRF membranes that were ready to be used in the surgical site."

DRUG

hemostatic agents with oxidized and regenerated cellulosa

In the Control Group hemostatic agents with oxidized and regenerated cellulosa were sutured to the palatal wound with mattress suture ( silk 5/0).

Trial Locations (1)

20142

Azienda Ospedaliera San Paolo - Polo Universitario - Università degli Studi di Milano, Milan

All Listed Sponsors
lead

Azienda Ospedaliera San Paolo

OTHER

NCT03685396 - Patient Morbidity After Palatal Free Gingival Grafts With or Without PRF Membranes Coverage | Biotech Hunter | Biotech Hunter